Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    3 0 0 0

Revue du rhumatisme
Volume 81, n° 1
pages 1-3 (janvier 2014)
Doi : 10.1016/j.rhum.2013.09.010
accepted : 16 September 2013
Les médicaments génériques posent-ils un problème en rhumatologie ?

Bernard Bannwarth a, , b , Marie Kostine a, Nicolas Poursac a
a Service de rhumatologie, groupe hospitalier Pèllegrin, CHU de Bordeaux, place Amélie-Raba-Léon, 33076 Bordeaux, France 
b Laboratoire de thérapeutique, université Bordeaux Segalen, 33076 Bordeaux, France 

Auteur correspondant.

Mots clés : Médicaments génériques, Bioéquivalence, Dénomination commune internationale (DCI), Rhumatologie, Bisphosphonates

 Ne pas utiliser, pour citation, la référence française de cet article, mais la référence anglaise de Joint Bone Spine avec le DOI ci-dessus.

© 2013  Société Française de Rhumatologie@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline